SEC Form D filing

FibroBiologics, Inc., 2025-12-16

An SEC Form D private-offering notice from Houston, TX, a $1,725,001 filer-stated offering target in Biotech. Filed 2025-12-16. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

FibroBiologics, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing fibroblast cell based therapies for chronic diseases such as wound healing, multiple sclerosis, disc degeneration and psoriasis.

Filed 2025-12-16Filed to raise $1,725,001First money in 2025-12-14Raised so far $1,725,001HQ (as filed) Houston, TXSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified fibrobiologics.com↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source